A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Arcus Biosciences, Inc.
City of Hope Medical Center
M.D. Anderson Cancer Center
Toray Industries, Inc
AstraZeneca
Valerio Therapeutics
National Institutes of Health Clinical Center (CC)